AU2015317893B2 - Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm - Google Patents

Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm Download PDF

Info

Publication number
AU2015317893B2
AU2015317893B2 AU2015317893A AU2015317893A AU2015317893B2 AU 2015317893 B2 AU2015317893 B2 AU 2015317893B2 AU 2015317893 A AU2015317893 A AU 2015317893A AU 2015317893 A AU2015317893 A AU 2015317893A AU 2015317893 B2 AU2015317893 B2 AU 2015317893B2
Authority
AU
Australia
Prior art keywords
nen
expression level
gep
cutoff value
predetermined cutoff
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015317893A
Other languages
English (en)
Other versions
AU2015317893A1 (en
Inventor
Ignat Drozdov
Mark Kidd
Irvin Mark MODLIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clifton Life Sciences LLC
Original Assignee
Clifton Life Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clifton Life Sciences LLC filed Critical Clifton Life Sciences LLC
Publication of AU2015317893A1 publication Critical patent/AU2015317893A1/en
Application granted granted Critical
Publication of AU2015317893B2 publication Critical patent/AU2015317893B2/en
Priority to AU2021212151A priority Critical patent/AU2021212151B2/en
Priority to AU2023258444A priority patent/AU2023258444A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2015317893A 2014-09-15 2015-09-15 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm Active AU2015317893B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2021212151A AU2021212151B2 (en) 2014-09-15 2021-08-06 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
AU2023258444A AU2023258444A1 (en) 2014-09-15 2023-11-03 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462050465P 2014-09-15 2014-09-15
US62/050,465 2014-09-15
PCT/US2015/050274 WO2016044330A1 (en) 2014-09-15 2015-09-15 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2021212151A Division AU2021212151B2 (en) 2014-09-15 2021-08-06 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm

Publications (2)

Publication Number Publication Date
AU2015317893A1 AU2015317893A1 (en) 2017-03-23
AU2015317893B2 true AU2015317893B2 (en) 2021-05-20

Family

ID=54207775

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2015317893A Active AU2015317893B2 (en) 2014-09-15 2015-09-15 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
AU2021212151A Active AU2021212151B2 (en) 2014-09-15 2021-08-06 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
AU2023258444A Pending AU2023258444A1 (en) 2014-09-15 2023-11-03 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2021212151A Active AU2021212151B2 (en) 2014-09-15 2021-08-06 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
AU2023258444A Pending AU2023258444A1 (en) 2014-09-15 2023-11-03 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm

Country Status (13)

Country Link
US (4) US10407730B2 (cg-RX-API-DMAC7.html)
EP (2) EP3194618B1 (cg-RX-API-DMAC7.html)
JP (2) JP6782700B2 (cg-RX-API-DMAC7.html)
KR (2) KR102762958B1 (cg-RX-API-DMAC7.html)
CN (1) CN107208132A (cg-RX-API-DMAC7.html)
AU (3) AU2015317893B2 (cg-RX-API-DMAC7.html)
CA (1) CA2959670C (cg-RX-API-DMAC7.html)
DK (2) DK3929303T3 (cg-RX-API-DMAC7.html)
ES (2) ES3013599T3 (cg-RX-API-DMAC7.html)
IL (2) IL250867B (cg-RX-API-DMAC7.html)
MX (2) MX386919B (cg-RX-API-DMAC7.html)
PL (2) PL3194618T3 (cg-RX-API-DMAC7.html)
WO (1) WO2016044330A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10407730B2 (en) 2014-09-15 2019-09-10 Clifton Life Sciences LLC Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
MX2019014026A (es) * 2017-05-25 2020-08-03 Liquid Biopsy Res Llc Metodos para la deteccion de melanoma.
CN118910259A (zh) * 2017-11-30 2024-11-08 液体活检研究有限责任公司 使用基因表达测定预测肽受体放射治疗
CN108048564B (zh) * 2018-02-09 2021-03-05 中国科学院昆明动物研究所 人glt8d1基因的新用途
US11948296B2 (en) * 2018-07-30 2024-04-02 Agency For Science, Technology And Research Method and system for assessing fibrosis in a tissue sample
EP4041886A1 (en) 2019-10-10 2022-08-17 Liquid Biopsy Research LLC Compositions, methods and kits for biological sample and rna stabilization
FR3110764B1 (fr) 2020-05-20 2024-05-10 Quantum Surgical Méthode de prédiction de la récidive d’une lésion par analyse d’images
CN113215255B (zh) * 2021-04-26 2022-04-05 山东天川精准医疗科技有限公司 用于肝癌早期诊断或预后的生物标记物及其用途
CN120153081A (zh) * 2022-07-15 2025-06-13 埃门多生物公司 Aplp2安全港位点敲入策略
CN120380169A (zh) * 2022-09-30 2025-07-25 液体活检研究有限责任公司 用于在唾液中检测神经内分泌癌的方法
CN117292755B (zh) * 2023-08-09 2026-02-06 郑州大学 多模态临界边生物标志物识别方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012119013A1 (en) * 2011-03-01 2012-09-07 Yale University PREDICTING GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NENs)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050084883A1 (en) 2003-08-25 2005-04-21 The Johns Hopkins University School Of Medicine Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differential gene expression analysis
JP5728380B2 (ja) * 2008-06-12 2015-06-03 シンタクシン リミテッドSyntaxin Limited 神経内分泌疾患の抑制
US10407730B2 (en) 2014-09-15 2019-09-10 Clifton Life Sciences LLC Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012119013A1 (en) * 2011-03-01 2012-09-07 Yale University PREDICTING GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NENs)

Also Published As

Publication number Publication date
AU2015317893A1 (en) 2017-03-23
US20260043085A1 (en) 2026-02-12
JP7157788B2 (ja) 2022-10-20
KR20170045365A (ko) 2017-04-26
IL281355B (en) 2022-02-01
JP2021019618A (ja) 2021-02-18
IL281355A (en) 2021-04-29
KR20250021631A (ko) 2025-02-13
US20220325351A1 (en) 2022-10-13
AU2021212151A1 (en) 2021-08-26
MX386919B (es) 2025-03-19
PL3194618T3 (pl) 2021-12-13
BR112017005279A2 (pt) 2017-12-12
CA2959670A1 (en) 2016-03-24
DK3929303T3 (da) 2025-03-03
AU2023258444A1 (en) 2023-11-23
MX2017003370A (es) 2017-11-22
US10407730B2 (en) 2019-09-10
EP3194618A1 (en) 2017-07-26
US11168372B2 (en) 2021-11-09
US20190345568A1 (en) 2019-11-14
AU2021212151B2 (en) 2023-08-03
EP3929303A1 (en) 2021-12-29
CA2959670C (en) 2024-02-20
JP6782700B2 (ja) 2020-11-11
CN107208132A (zh) 2017-09-26
PL3929303T3 (pl) 2025-04-28
US12258633B2 (en) 2025-03-25
EP3194618B1 (en) 2021-04-21
MX2021012347A (es) 2021-10-22
IL250867A0 (en) 2017-04-30
JP2017528164A (ja) 2017-09-28
DK3194618T3 (da) 2021-07-12
WO2016044330A1 (en) 2016-03-24
EP3929303B1 (en) 2024-12-04
ES3013599T3 (en) 2025-04-14
KR102762958B1 (ko) 2025-02-04
IL250867B (en) 2021-03-25
ES2881474T3 (es) 2021-11-29
US20160076106A1 (en) 2016-03-17

Similar Documents

Publication Publication Date Title
AU2021212151B2 (en) Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
JP7539443B2 (ja) 癌の分類および予後
AU2017204086B2 (en) Predicting gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs)
US20210233611A1 (en) Classification and prognosis of prostate cancer
CA3213101A1 (en) Methods and systems for detecting cancer via nucleic acid methylation analysis
HK40066027A (en) Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
HK40066027B (en) Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
HK1241416B (en) Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
BR112017005279B1 (pt) Métodos para detectar um neoplasma neuroendócrino gastroenteropancreático (gep-nen), para diferenciar gep-nen estável de um gep-nen progressivo e para determinar uma resposta a uma terapia com radionucleotídeo para receptor de peptídeo de um gep-nen
HK1193127A (en) Evaluating response to therapy of gastroenteropancreatic neuroendocrine neoplasms (gep-nens)
HK1193127B (en) Evaluating response to therapy of gastroenteropancreatic neuroendocrine neoplasms (gep-nens)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)